课题基金 / 基金详情

ETIB Clinical Research Core

ETIB Clinical Research Core
ETIB 临床研究核心
批准号:
10703100
负责人:
Ronald Gress
金额:
$130.78万
依托单位国家:
美国
项目类别:
财政年份:
--
资助国家:
美国
项目状态:
未结题
起止时间:

项目摘要

项目成果

Ronald Gress的其他基金

相似基金

相关文献

中文摘要
翻译
实验移植和免疫学分部(ETIB)临床移植计划的目标是通过造血干细胞移植疗法治愈癌症,进行杰出的翻译研究,并提供最高水平的临床护理。ETIB临床核心提供整个分支机构的互动、活动和支持。它代表了在临床移植和临床研究方面每个人都具有特定专业知识的个人的集合。虽然该部门的作用是协调一致的,但它也是为成员的个人职业发展和职业发展而设计的。具体目标包括为进行临床移植试验建立一个支持性的基础设施,在移植患者的护理方面建立一致的临床政策和做法,以实现卓越的临床护理,以及提供和促进造血干细胞移植的教育机会。
英文摘要
The Experimental Transplantation and Immunology Branch (ETIB) clinical transplantation program has as goals the cure of cancer through hematopoietic stem cell transplant therapies, conducting outstanding translational research, and providing the highest level of excellence in clinical care. The ETIB Clinical Core provides interactions, activities and support across the branch. It represents a collection of individuals each with particular expertise in clinical transplantation and clinical research. While the section functions as a coordinated effort, it is also designed for individual career development and professional advancement for members. Specific aims include developing a supportive infrastructure for the conduct of clinical transplantation trials, establishing consistent clinical policies and practices in the care of transplantation patients in order to achieve excellence in clinical care, and providing and promoting educational opportunities in hematopoietic stem cell transplantation.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
ETIB Clinical Research Core
Immune Reconstitution
ETIB Clinical Research Core
ETIB Clinical Trials
  • 批准号:
    10702441
  • 项目类别:
  • 资助金额:
    $333.48万
  • 财政年份:
    --
  • 负责人:
    Ronald Gress
  • 依托单位:
国内基金
海外基金
Molecular Interaction Reconstruction of Rheumatoid Arthritis Therapies Using Clinical Data